期刊
DIGESTIVE AND LIVER DISEASE
卷 46, 期 3, 页码 257-263出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.dld.2013.10.015
关键词
Hepatocellular carcinoma; Liver function; Monte Carlo simulation; Radiofrequency ablation; Survival; Surgical therapy
资金
- Region of Emilia Romagna
Background: Whether to prefer hepatic resection or radiofrequency ablation as first line therapy for hepatocellular carcinoma is a matter of debate. Aims: To compare outcomes of resection and ablation, in the treatment of early hepatocellular carcinoma, through a decision-making analysis. Methods: Data of 388 cirrhotic patients undergoing resection and of 207 undergoing radiofrequency ablation were reviewed. Two distinct regression models were devised and used to perform sensitivity and probabilistic analyses, to overcome biases of covariate distributions. Results: Actuarial survival curves showed no difference between resection and ablation (P = 0.270) despite the fact that ablated patients were older, with worse liver function and smaller, unifocal tumours (P < 0.05), suggesting a complex, non-linear relationship between clinical, tumoral variables and treatments. Sensitivity and probabilistic analyses suggested that the superiority of resection over ablation decreased at higher Model for-End stage Liver Disease scores, and that ablation provided better results for smaller tumours and higher Model for-End stage Liver Disease scores. In patients with 2-3 tumours up to 3 cm, the two treatments produced opposite comparative results in relation to the Model for-End stage Liver Disease score. Conclusions: The superiority, or the equivalence, of resection and ablation depends on the non-linear relationship existing between treatment, tumour number, size and degree of liver dysfunction. (C) 2013 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据